1. Home
  2. RPID vs VXRT Comparison

RPID vs VXRT Comparison

Compare RPID & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPID
  • VXRT
  • Stock Information
  • Founded
  • RPID 2006
  • VXRT N/A
  • Country
  • RPID United States
  • VXRT United States
  • Employees
  • RPID N/A
  • VXRT N/A
  • Industry
  • RPID Medical Specialities
  • VXRT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RPID Health Care
  • VXRT Health Care
  • Exchange
  • RPID Nasdaq
  • VXRT Nasdaq
  • Market Cap
  • RPID 145.1M
  • VXRT 119.0M
  • IPO Year
  • RPID 2021
  • VXRT N/A
  • Fundamental
  • Price
  • RPID $3.33
  • VXRT $0.43
  • Analyst Decision
  • RPID Buy
  • VXRT Strong Buy
  • Analyst Count
  • RPID 1
  • VXRT 2
  • Target Price
  • RPID $8.00
  • VXRT $3.00
  • AVG Volume (30 Days)
  • RPID 163.7K
  • VXRT 1.8M
  • Earning Date
  • RPID 05-09-2025
  • VXRT 05-13-2025
  • Dividend Yield
  • RPID N/A
  • VXRT N/A
  • EPS Growth
  • RPID N/A
  • VXRT N/A
  • EPS
  • RPID N/A
  • VXRT N/A
  • Revenue
  • RPID $29,645,000.00
  • VXRT $47,395,000.00
  • Revenue This Year
  • RPID $18.54
  • VXRT N/A
  • Revenue Next Year
  • RPID $20.55
  • VXRT N/A
  • P/E Ratio
  • RPID N/A
  • VXRT N/A
  • Revenue Growth
  • RPID 28.36
  • VXRT 433.43
  • 52 Week Low
  • RPID $0.58
  • VXRT $0.29
  • 52 Week High
  • RPID $4.04
  • VXRT $1.07
  • Technical
  • Relative Strength Index (RSI)
  • RPID 61.61
  • VXRT 48.78
  • Support Level
  • RPID $3.15
  • VXRT $0.44
  • Resistance Level
  • RPID $3.84
  • VXRT $0.48
  • Average True Range (ATR)
  • RPID 0.27
  • VXRT 0.04
  • MACD
  • RPID 0.02
  • VXRT -0.00
  • Stochastic Oscillator
  • RPID 50.96
  • VXRT 37.12

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

About VXRT Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Share on Social Networks: